Vefron

ACTIVE INGREDIENT

Ondansetron Hydrochloride

INDICATIONS

  • Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy or radiotherapy.

  • Prevention of postoperative nausea and/or vomiting.

FORMS

  • fc. tab 8 mg x 15

  • inj sol 8 mg/4 ml-vial x 1

T.: 210 9423677   info@opusmateria.gr

THE COMPANY

© 2019 BY FM STUDIO

CONTACT INFORMATION

33 Konstantinou Palaiologou street, Palaio Faliro, Attica, Greece.

175 64

+30 210 9423 677

info@opusmateria.gr